ACTRN12617000851369
Withdrawn
Phase 2
Comparison between the efficacy and the safety of ketamine and dexmedetomidine as adjuvants in PEC1 and PEC2 regional blocks for perioperative pain control for patients undergoing breast cancer surgery,A controlled prospective double blind randomized study.
Amira Soliman0 sites90 target enrollmentJune 8, 2017
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Amira Soliman
- Enrollment
- 90
- Status
- Withdrawn
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients American Society of Anesthesiologists (ASA) classification score 1 to 3 scheduled for modified radical mastectomy
Exclusion Criteria
- •patients with history of advanced cardiac disease or having sepsis, Those with prior surgery in areas above or below the clavicle or in the axillary region, Those with opioid dependence or alcohol or drug abuse, those with coagulopathy p, and those with psychiatric illness that prevent them from proper perception and assessment of pain,
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To study and compare the effect of prednisolone acetate and nepafenac eyedrops in patients after surgery for cloudy lens (safed motiya)Health Condition 1: H269- Unspecified cataractCTRI/2023/01/049131Pt B D Sharma PGIMS Rohtak43
Not yet recruiting
Phase 2
Comparison of the effect of Tulsi and Chlorhexidine mouth rinse on gum disease in controlled sugar patients aged 45-55 years in Davangere city.CTRI/2019/01/016960il
Completed
Not Applicable
comparison of various respiratory medicines in patients with chronic airway disease of prolong duratioHealth Condition 1: null- chronic obstructive pulmonary diseaseHealth Condition 2: J449- Chronic obstructive pulmonary disease, unspecifiedHealth Condition 3: J449- Chronic obstructive pulmonary disease, unspecifiedCTRI/2018/06/014573Department of pharmacology160
Not yet recruiting
Phase 4
To assess and compare the effectiveness and safety of olopatadine 0.7 percent and alcatadine 0.25 percent in patients with allergic conjunctivitis.CTRI/2024/05/067217Pt B.D. Sharma UHS Rohtak
Unknown
Not Applicable
Comparison between 3 surgical treatments in stable vitiligo patientsHealth Condition 1: L80- VitiligoCTRI/2019/11/021900GCS Medical college Hospital and Research center6